Cause of death among patients with Parkinson's disease: a rare mortality due to cerebral haemorrhage
- PMID: 2355241
- DOI: 10.1007/BF00314665
Cause of death among patients with Parkinson's disease: a rare mortality due to cerebral haemorrhage
Abstract
Causes of death, with special reference to cerebral haemorrhage, among 240 patients with pathologically verified Parkinson's disease were investigated using the Annuals of the Pathological Autopsy Cases in Japan from 1981 to 1985. The leading causes of death were pneumonia and bronchitis (44.1%), malignant neoplasms (11.6%), heart diseases (4.1%), cerebral infarction (3.7%) and septicaemia (3.3%). Cerebral haemorrhage was the 11th most frequent cause of death, accounting for only 0.8% of deaths among the patients, whereas it was the 5th most common cause of death among the Japanese general population in 1985. The low incidence of cerebral haemorrhage as a cause of death in patients with Parkinson's disease may reflect the hypotensive effect of levodopa and a hypotensive mechanism due to reduced noradrenaline levels in the parkinsonian brain.
Similar articles
-
Prevalence of stroke in Parkinson's disease: a postmortem study.Mov Disord. 2002 Jul;17(4):772-4. doi: 10.1002/mds.10199. Mov Disord. 2002. PMID: 12210874
-
Investigation by Parkinson's Disease Research Group of United Kingdom into excess mortality seen with combined levodopa and selegiline treatment in patients with early, mild Parkinson's disease: further results of randomised trial and confidential inquiry.BMJ. 1998 Apr 18;316(7139):1191-6. doi: 10.1136/bmj.316.7139.1191. BMJ. 1998. PMID: 9583926 Free PMC article. Clinical Trial.
-
Local cerebral blood flow and its response to intravenous levodopa in progressive supranuclear palsy. Comparison with Parkinson's disease.Arch Neurol. 1992 Jul;49(7):725-30. doi: 10.1001/archneur.1992.00530310071014. Arch Neurol. 1992. PMID: 1497499
-
[From Parkinson's disease to Lewy body disease].Presse Med. 1992 Apr 18;21(15):708-12. Presse Med. 1992. PMID: 1534893 Review. French.
-
Respiratory dysfunction in Parkinson's disease.Clin Chest Med. 1994 Dec;15(4):715-27. Clin Chest Med. 1994. PMID: 7867286 Review.
Cited by
-
From Mitochondrial Function to Neuroprotection-an Emerging Role for Methylene Blue.Mol Neurobiol. 2018 Jun;55(6):5137-5153. doi: 10.1007/s12035-017-0712-2. Epub 2017 Aug 24. Mol Neurobiol. 2018. PMID: 28840449 Free PMC article. Review.
-
Association between smoking and all-cause mortality in Parkinson's disease.NPJ Parkinsons Dis. 2023 Apr 11;9(1):59. doi: 10.1038/s41531-023-00486-0. NPJ Parkinsons Dis. 2023. PMID: 37037842 Free PMC article.
-
Gastro-intestinal dysfunctions in Parkinson's disease (Review).Exp Ther Med. 2021 Oct;22(4):1083. doi: 10.3892/etm.2021.10517. Epub 2021 Jul 29. Exp Ther Med. 2021. PMID: 34447476 Free PMC article. Review.
-
Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies.Mov Disord. 2018 Mar;33(3):372-390. doi: 10.1002/mds.27344. Mov Disord. 2018. PMID: 29508455 Free PMC article. Review.
-
Abnormal neural oscillations during gait and dual-task in Parkinson's disease.Front Syst Neurosci. 2022 Sep 15;16:995375. doi: 10.3389/fnsys.2022.995375. eCollection 2022. Front Syst Neurosci. 2022. PMID: 36185822 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Medical